Clinical trials of an mRNA vaccine have begun, and researchers expect broadly positive outcomes in the fight against the widespread illness.
XBB. 1.5 and other subvariants do signal a change in how the virus is mutating. Here’s what this means for Australia and globally.
The Omicron strain is driving a rapid increase in China, and is quicker to transmit than other variants.
Unclear and often mixed messages have contributed to public confusion that has arguably placed people’s health at risk.
The pandemic stretched our healthcare system to breaking point, but it also proved how new and positive models of screening and care can quickly be created in adversity.
2022 will be the year we finally have all the means, measures, and tools to control the pandemic to a non-lethal state.
At this stage it’s hard to know for sure why Melbourne’s COVID numbers are higher, but it’s likely that climate plays a role.
The new phase of the pandemic will come with a period of uncertainty as we adjust to “living with the virus” and a see-sawing of some restrictions.
The new variant of interest, detected in 42 countries, possesses a “constellation of mutations that indicate potential properties of immune escape”.
There are three measures for assessing whether public policy is successful, and the Coalition has been found wanting on all three. But there’s one policy area that’s an even bigger disaster.
The case is growing stronger for COVID-19 vaccine mixing-and-matching, with recent data showing high efficacy and protection against SARS-CoV-2 virus strains.
The rare blood-clotting issues associated with the Astra-Zeneca vaccine have recently made headlines, but it's too early to say whether it will increase overall vaccine hesitancy.
COVID-19 vaccine tourism has swiftly evolved into a thriving global industry as people look to secure a quick vaccination fix.
Scientists are well-advanced in mapping the way forward to develop and repurpose medicines for respiratory virus patients in the post-COVID era.
Dr Harry Al-Wassiti, Research Fellow at the Monash Institute of Pharmaceutical Sciences (MIPS), answers the questions about the jab that's on everyone's mind.
We'll struggle to find a vaccine that works perfectly for people who need it most, despite what the headlines say is coming in 2021.
A behind-the-scenes look at the two vaccine candidates being developed by Monash University and the Doherty Institute.
The COVID-19 death toll in aged-care homes is spiking. Protocols need to urgently be put in place to prevent infection, but there also needs to be detailed plans for when an outbreak occurs.
There's deep concern for the impact a second or third COVID-19 wave could have on Indigenous Australians.
How likely is it that we'll have a relatively quick fix for COVID-19, and what are the hurdles?
Until we truly know what we're fighting, loosening COVID-19 restrictions and resuming our previous normal lives could be a mistake.
A new collection project aims to crack the COVID-19 immunity code, and predict who will be hardest-hit.
While we've so far successfully contained COVID-19, the modelling clearly shows now isn't the time to relax many of the restrictions.
Researchers have repurposed existing tools to make a COVID-19 immunity test breakthrough.
Dummy text
